Ethris Receives €10 Million EU4Health Grant to Support Clinical Development and Expand Antiviral Applications of Lead mRNA Candidate ETH47
ETH47 is a first-in-class mRNA antiviral therapy with broad-spectrum potential The project will generate key preclinical and clinical data to validate ETH47’s... Read more.
Lineage Expands Nordic Presence with Strategic Acquisition of Permanor AS in Norway
Lineage completes acquisition of Permanor AS, strengthening its cold storage and logistics capabilities across Norway and the broader Nordic region. The operations... Read more.
Kosmos Energy Announces First Quarter 2025 Results
DALLAS–(BUSINESS WIRE)–Kosmos Energy Ltd. (“Kosmos” or the “Company”) (NYSE/LSE: KOS) announced today its financial and operating results for... Read more.
Pacific Prime Dubai Awarded Bupa Global’s SME Retention Award
DUBAI, United Arab Emirates–(BUSINESS WIRE)–Pacific Prime Dubai, a leader in international health insurance and employee benefits solutions, is proud... Read more.
HAFNIA LIMITED: Audited Financial Statements 2024
SINGAPORE–(BUSINESS WIRE)–Hafnia Limited (“Hafnia”, the “Company”, OSE ticker code: “HAFNI”, NYSE ticker code: “HAFN”)... Read more.
BW LPG Limited – Q1 2025 Financial Report Release and Earnings Presentation on 20 May 2025
SINGAPORE–(BUSINESS WIRE)–BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG.OL”, NYSE ticker code: “BWLP”) will release... Read more.
Innate Pharma announces conference call and webcast for Q1 2025 business update
MARSEILLE, France–(BUSINESS WIRE)–#innatepharma–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”),... Read more.
RSA Announces New Innovations to Stop Help Desk Scams and Protect Passwordless Environments
BERLIN–(BUSINESS WIRE)–RSA, the security-first identity leader, today announced groundbreaking cybersecurity innovations at the European Identity and... Read more.
CORRECTING and REPLACING AstroNova to Nominate Six Highly Qualified Directors for Election at 2025 Shareholder Meeting
WEST WARWICK, R.I.–(BUSINESS WIRE)–Please note that a year referenced in one of the director biographies has been corrected from 2022 to 2002. The... Read more.
Owkin Launches K Navigator, a Ground-breaking Agentic Co-pilot to Speed up Breakthroughs in Biomedical Research by 20x
K Navigator increases researcher productivity by 20x¹, accelerating biomedical breakthroughs and outperforming leading generalist LLMs Analyzes and visualizes multimodal... Read more.